6 min readinformational
Scientists Just Grew Hair in a Lab — And Yeah, It Could Actually Cure Baldness
TF
ToolsFuel Team
Web development tools & tips
Photo by ThisisEngineering on Unsplash
Table of Contents
So... They Can Grow Hair in a Dish Now?
I'm not gonna lie — when I saw the headline, I figured it was clickbait. "Fully functional hair follicles grown in a lab for the first time." Right. I've been reading "we're 5 years from curing baldness" since college, and my buddy's hairline hasn't gotten the memo.
But this one's legit. A team from Riken (a Japanese research institute) and a startup called OrganTech actually grew hair follicles in a petri dish. When they transplanted them onto mice, the follicles sprouted real hair, connected to nerves and muscles, and went through natural growth cycles. The hair fell out and grew back. On its own. For over 68 days.
That's not a wig glued to a mouse. That's a working organ system.
But this one's legit. A team from Riken (a Japanese research institute) and a startup called OrganTech actually grew hair follicles in a petri dish. When they transplanted them onto mice, the follicles sprouted real hair, connected to nerves and muscles, and went through natural growth cycles. The hair fell out and grew back. On its own. For over 68 days.
That's not a wig glued to a mouse. That's a working organ system.
The Missing Piece Nobody Knew About
Photo by CDC on Unsplash
For decades, researchers tried growing follicles using two cell types: epithelial stem cells (which build the actual hair) and dermal papilla cells (which send growth signals). Makes sense on paper. Didn't work in practice.
The breakthrough? A third cell type everyone had been overlooking — accessory mesenchymal cells. I'll spare you the full biology lecture, but here's the analogy that clicked for me: if epithelial cells are the blueprint and dermal papilla cells are the architect, these mesenchymal cells are the construction crew that pours the foundation.
Without them, follicles would kinda-sorta form but never root deeply enough into skin to produce a real hair shaft. Add the third cell type, and suddenly everything snaps into place. Full follicles. Real hair shafts. Natural growth cycles that repeat without intervention.
The paper dropped in Biochemical and Biophysical Research Communications, and it's been lighting up biotech circles ever since.
The breakthrough? A third cell type everyone had been overlooking — accessory mesenchymal cells. I'll spare you the full biology lecture, but here's the analogy that clicked for me: if epithelial cells are the blueprint and dermal papilla cells are the architect, these mesenchymal cells are the construction crew that pours the foundation.
Without them, follicles would kinda-sorta form but never root deeply enough into skin to produce a real hair shaft. Add the third cell type, and suddenly everything snaps into place. Full follicles. Real hair shafts. Natural growth cycles that repeat without intervention.
The paper dropped in Biochemical and Biophysical Research Communications, and it's been lighting up biotech circles ever since.
Why Everything You Can Buy Right Now Kinda Sucks
Photo by Donald Teel on Unsplash
Let's talk about what's actually available in 2026 if your hair's thinning. Spoiler: it's not great.
**Minoxidil** (you know it as Rogaine): Rub it on your scalp twice a day, every day, forever. It boosts blood flow to follicles and keeps them in the growth phase longer. Works for maybe 40% of people. Stop using it and everything falls out within months. Fun.
**Finasteride** (Propecia): A daily pill that blocks DHT — the hormone responsible for shrinking your follicles. More effective than minoxidil, with 80-90% of guys keeping what they've got. But the side effects are why half the guys I know won't touch it: erectile dysfunction, depression, brain fog, decreased libido. Most people tolerate it fine, but nobody wants to roll those dice.
**Hair transplants**: You're paying $4,000-$15,000 to relocate hair from the back of your head to the front. Results are decent but you need enough donor hair to work with. It's rearranging deck chairs, not creating new ones.
None of these grow new hair from nothing. That's why the lab-grown approach is a completely different ball game.
**Minoxidil** (you know it as Rogaine): Rub it on your scalp twice a day, every day, forever. It boosts blood flow to follicles and keeps them in the growth phase longer. Works for maybe 40% of people. Stop using it and everything falls out within months. Fun.
**Finasteride** (Propecia): A daily pill that blocks DHT — the hormone responsible for shrinking your follicles. More effective than minoxidil, with 80-90% of guys keeping what they've got. But the side effects are why half the guys I know won't touch it: erectile dysfunction, depression, brain fog, decreased libido. Most people tolerate it fine, but nobody wants to roll those dice.
**Hair transplants**: You're paying $4,000-$15,000 to relocate hair from the back of your head to the front. Results are decent but you need enough donor hair to work with. It's rearranging deck chairs, not creating new ones.
None of these grow new hair from nothing. That's why the lab-grown approach is a completely different ball game.
PP405 Might Actually Beat Them All to Your Scalp
While lab-grown follicles grab the headlines, there's another contender that could reach your bathroom shelf way sooner.
Pelage Pharmaceuticals has a drug called PP405, and it works completely differently from anything else on the market. Minoxidil targets blood flow. Finasteride blocks hormones. PP405 goes straight for the energy metabolism of your follicle stem cells.
Here's the short version (I had to read the paper three times to get this): PP405 inhibits something called mitochondrial pyruvate carriers, which causes pyruvate to build up, which cranks up lactic acid production in hair follicle stem cells. Higher lactic acid = the cell switches from "dormant mode" to "active growth mode." It's essentially flipping a metabolic switch that wakes up sleeping follicles.
In Phase 2a trials, 31% of men with significant hair loss saw more than 20% increase in hair density. The placebo group? Zero percent. That's a real result.
Pelage just raised $120 million in Series B funding, and Phase 3 trials are kicking off this year. If everything lines up — and that's a massive if — FDA approval could come by 2027-2029.
Pelage Pharmaceuticals has a drug called PP405, and it works completely differently from anything else on the market. Minoxidil targets blood flow. Finasteride blocks hormones. PP405 goes straight for the energy metabolism of your follicle stem cells.
Here's the short version (I had to read the paper three times to get this): PP405 inhibits something called mitochondrial pyruvate carriers, which causes pyruvate to build up, which cranks up lactic acid production in hair follicle stem cells. Higher lactic acid = the cell switches from "dormant mode" to "active growth mode." It's essentially flipping a metabolic switch that wakes up sleeping follicles.
In Phase 2a trials, 31% of men with significant hair loss saw more than 20% increase in hair density. The placebo group? Zero percent. That's a real result.
Pelage just raised $120 million in Series B funding, and Phase 3 trials are kicking off this year. If everything lines up — and that's a massive if — FDA approval could come by 2027-2029.
The Honest Timeline Nobody Wants to Hear
So when can you actually walk into a clinic and say "grow me some hair, please"?
For lab-grown follicles: not anytime soon. The mouse results are exciting, but human skin is a different beast entirely. Small-scale clinical trials might start in 2026, but we're realistically looking at 10+ years before any treatment hits the market. The research team still needs to figure out how to scale from a handful of follicles to the thousands you'd need for real coverage, whether human skin responds the same way, and how to keep costs from being astronomical.
For PP405: 2027-2029 for approval, if Phase 3 goes well. That's the fastest horse in this race.
There's also clascoterone — another drug with strong Phase 3 data expected by spring 2026 and FDA submissions shortly after.
My take? We're genuinely closer to meaningful solutions than we've ever been. But I've watched enough "breakthrough" treatments fizzle in clinical trials to stay cautiously optimistic rather than buying champagne.
For lab-grown follicles: not anytime soon. The mouse results are exciting, but human skin is a different beast entirely. Small-scale clinical trials might start in 2026, but we're realistically looking at 10+ years before any treatment hits the market. The research team still needs to figure out how to scale from a handful of follicles to the thousands you'd need for real coverage, whether human skin responds the same way, and how to keep costs from being astronomical.
For PP405: 2027-2029 for approval, if Phase 3 goes well. That's the fastest horse in this race.
There's also clascoterone — another drug with strong Phase 3 data expected by spring 2026 and FDA submissions shortly after.
My take? We're genuinely closer to meaningful solutions than we've ever been. But I've watched enough "breakthrough" treatments fizzle in clinical trials to stay cautiously optimistic rather than buying champagne.
What I'd Actually Do About It Right Now
Look — I'm not a dermatologist. Don't take hair advice from a blog post. Talk to an actual doctor. But if I were personally watching my hairline creep backward, here's my game plan.
Start with what works today. Minoxidil or finasteride under a doctor's guidance. They're not perfect, but buying time is the whole strategy right now. The longer you hold onto what you've got, the better your chances of catching something better when it arrives.
Keep tabs on PP405 trials. If Phase 3 delivers, this could genuinely change things. You can sign up for clinical trial notifications at clinicaltrials.gov if you want to stay in the loop.
And for the love of everything — stop buying "natural hair regrowth" supplements from Instagram ads. Your scalp doesn't care about biotin gummies, okay? If a product promises miraculous regrowth with zero side effects and all-natural ingredients, it's lying to you. Sorry.
The lab-grown follicle breakthrough is the real deal as science. Not marketing hype, not clickbait — actual peer-reviewed research. But it's the start of a very long road, not the finish line. The good news? For the first time in decades, there are multiple roads heading somewhere real.
Start with what works today. Minoxidil or finasteride under a doctor's guidance. They're not perfect, but buying time is the whole strategy right now. The longer you hold onto what you've got, the better your chances of catching something better when it arrives.
Keep tabs on PP405 trials. If Phase 3 delivers, this could genuinely change things. You can sign up for clinical trial notifications at clinicaltrials.gov if you want to stay in the loop.
And for the love of everything — stop buying "natural hair regrowth" supplements from Instagram ads. Your scalp doesn't care about biotin gummies, okay? If a product promises miraculous regrowth with zero side effects and all-natural ingredients, it's lying to you. Sorry.
The lab-grown follicle breakthrough is the real deal as science. Not marketing hype, not clickbait — actual peer-reviewed research. But it's the start of a very long road, not the finish line. The good news? For the first time in decades, there are multiple roads heading somewhere real.
Frequently Asked Questions
Can lab-grown hair follicles cure baldness?
Lab-grown follicles have successfully produced real, cycling hair in mice for the first time. But human trials haven't started yet, and a commercially available treatment is likely a decade or more away. It's a major breakthrough, but not something you can access today.
What is PP405 and how does it treat hair loss?
PP405 is a new drug by Pelage Pharmaceuticals that reactivates dormant hair follicle stem cells by altering their energy metabolism. Unlike minoxidil or finasteride, it targets mitochondrial pyruvate carriers to boost cellular energy and trigger growth. Phase 3 trials begin in 2026.
Are lab-grown hair follicles better than hair transplants?
Potentially, yes. Lab-grown follicles could create unlimited new hair without needing donor hair from elsewhere on your scalp. But the technology is still in early research stages and hasn't been tested in humans yet.
When will a cure for baldness be available?
The most optimistic timeline for lab-grown follicle treatments is 10+ years away. PP405 could reach the market by 2027-2029 if clinical trials succeed. Clascoterone is another promising treatment that may receive FDA approval around the same timeframe.
What causes male pattern baldness?
Male pattern baldness (androgenetic alopecia) is primarily caused by genetics and the hormone DHT, which gradually shrinks hair follicles over time. It affects roughly 85% of men by age 50, with many noticing thinning as early as their 20s.
Try ToolsFuel
23+ free online tools for developers, designers, and everyone. No signup required.
Browse All Tools